DescriptionThe ProDots Recombinant Human IFN-gamma Protein is derived from E. coli. The ProDots Recombinant Human IFN-gamma Protein has been validated for the following applications: Bioactivity.
|IFG, IFI, IFNG, IFNgamma, IFN-gamma, Immune interferon, interferon gamma, interferon, gamma|
|<0.10 EU per 1μg of the protein by the LAL method.|
|Source: E. coli-derived Gln24 - Gln166; N Terminal Sequence: Met|
|>97%, by SDS-PAGE under reducing conditions and visualized by silver stain|
|Predicted MW: 16.9kDa Observed MW: 17kDa, reducing conditions|
|Measured in anti-viral assays using HeLa human cervical epithelial carcinoma cells infected with encephalomyocarditis (EMC) virus. Meager, A. (1987) in Lymphokines and Interferons, a Practical Approach. Clemens, M.J. et al. (eds): IRL Press. 129. The ED50 for this effect is typically 0.15-0.75ng/mL.|
|E. coli-derived Gln24 - Gln166|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok